(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl) chroman-4-one for COVID-19

 (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl) chroman-4-one has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl) chroman-4-one in detail.
Ran et al., Scutellaria barbata D. Don extracts alleviate SARS-CoV-2 induced acute lung injury by inhibiting virus replication and bi-directional immune modulation, Virologica Sinica, doi:10.1016/j.virs.2025.04.004